Moreover, the levels of MAPKs including phosphorylation ERK1/2 and JNK1/2 were differentially increased in CD44(+)-HNSCC by western blot (Fig. 4b). This evidence concerns the gene MAPK3 and head and neck squamous cell carcinoma.